BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18252146)

  • 21. [A case of Giant GIST of the stomach successfully treated with imatinib mesylate neoadjuvant therapy and followed postoperatively].
    Okuda H; Tanaka H; Ueno M; Shitani M; Nasuno M; Suzuki C; Nishimura S; Kimura H; Yonezawa K; Abe T; Yoshida Y; Kawabata M
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1941-4. PubMed ID: 16282731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expert consensus on surgical treatment for gastrointestinal stromal tumors].
    Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):947-8. PubMed ID: 18478940
    [No Abstract]   [Full Text] [Related]  

  • 23. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant and down-staging treatment with imatinib in gastrointestinal stromal tumors.
    Nilsson B; Andersson A; Ahlman H
    J Surg Oncol; 2008 Sep; 98(3):145-6. PubMed ID: 18452216
    [No Abstract]   [Full Text] [Related]  

  • 25. Downstaging of a gastric GIST by neoadjuvant imatinib and endoscopic assisted laparoscopic resection.
    Cavaliere D; Vagliasindi A; Mura G; Framarini M; Giorgetti G; Solfrini G; Tauceri F; Padovani F; Milandri C; Dubini A; Ridolfi L; Ricci E; Verdecchia GM
    Eur J Surg Oncol; 2007 Oct; 33(8):1044-6. PubMed ID: 17467951
    [No Abstract]   [Full Text] [Related]  

  • 26. Surgical options in the treatment of GIST of the upper portion of the stomach. Report of two cases.
    Cavallaro G; Paparelli C; Polistena A; Fornari F; Ruperto M; De Toma G
    Ann Ital Chir; 2007; 78(2):133-6. PubMed ID: 17583124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST).
    Nilsson B; Sjölund K; Kindblom LG; Meis-Kindblom JM; Bümming P; Nilsson O; Andersson J; Ahlman H
    Br J Cancer; 2007 Jun; 96(11):1656-8. PubMed ID: 17533389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Two cases of recurrent GIST successfully treated with imatinib mesylate at 100mg/day].
    Hanada N; Kawata K; Okamura S; Tomiyama N; Hori K
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):803-5. PubMed ID: 23863663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Surgical treatment of an advanced GIST the age of imatinib].
    Fernández JA; Parrilla P
    Cir Esp; 2009 Jul; 86(1):3-12. PubMed ID: 19539273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is imatinib justified as an adjuvant chemotherapy for patients with recurrent gastrointestinal stromal tumors.
    Lai IR; Hu RH; Chang KJ
    Hepatogastroenterology; 2005; 52(63):826-8. PubMed ID: 15966213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Education and imaging. Gastrointestinal: Sister Mary Joseph nodule.
    Lin CC; Liu KL; Lin JT; Lin MT; Wang HP
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1462. PubMed ID: 18854004
    [No Abstract]   [Full Text] [Related]  

  • 32. [A case of extragastric pedunculated gastrointestinal stromal tumor of the stomach with peritoneal dissemination].
    Kikuchi A; Liu B; Chikatani K; Nishida K; Kawashima H; Miyamoto H; Kakimoto M; Goto H; Yoshimura T; Koshiishi H; Okamura T
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2387-9. PubMed ID: 23268086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant and neoadjuvant therapy for primary GIST.
    Eisenberg BL; Smith KD
    Cancer Chemother Pharmacol; 2011 Jan; 67 Suppl 1():S3-8. PubMed ID: 21116626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gastrointestinal stromal tumors (GIST)].
    Galbfach PJ; Langner EB; Czapiński-Tuzikiewicz T; Sroda A; Spychalski MI; Dziki AJ
    Wiad Lek; 2007; 60(3-4):114-9. PubMed ID: 17726861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should adjuvant imatinib be used as primary treatment for gastrointestinal stromal tumors?
    Hohenberger P
    Nat Clin Pract Oncol; 2008 May; 5(5):240-1. PubMed ID: 18349856
    [No Abstract]   [Full Text] [Related]  

  • 36. A case of hepatic metastasis from gastric GIST successfully resected following neoadjuvant targeted therapy.
    Onoe S; Sakamoto Y
    Jpn J Clin Oncol; 2011 Apr; 41(4):590. PubMed ID: 21447695
    [No Abstract]   [Full Text] [Related]  

  • 37. Primary extra-gastrointestinal stromal tumor of the omentum.
    Divakaran J; Chander B
    J Cancer Res Ther; 2012; 8(3):433-5. PubMed ID: 23174729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successes and challenges in translational research: the development of targeted therapy for gastrointestinal stromal tumours.
    Renouf DJ; Wilson L; Blanke CD
    Clin Cancer Res; 2009 Jun; 15(12):3908-11. PubMed ID: 19509180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Two cases of postoperative recurrence of gastric GIST treated by imatinib].
    Kikuchi H; Konn H; Kamiya K; Baba M; Ohta M; Kondo K; Hiramatsu Y; Yamamoto M; Tanaka T; Sugimura H; Ohashi M; Kanda T; Nakamura S
    Gan To Kagaku Ryoho; 2004 Oct; 31(10):1569-73. PubMed ID: 15508453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of huge GIST of the stomach successfully resected following effective neoadjuvant chemotherapy.
    Tanaka N; Saka M
    Jpn J Clin Oncol; 2008 Nov; 38(11):790. PubMed ID: 18952707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.